Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Blood -- Transfusion. --- Burns and scalds -- Surgery. --- Blood --- Burns and scalds --- Body Fluids --- Biological Therapy --- Fluids and Secretions --- Therapeutics --- Blood Transfusion --- Anatomy --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Medicine --- Health & Biological Sciences --- Hematologic Diseases --- Transfusion --- Surgery --- Transfusion. --- Surgery. --- Burn trauma --- Scalds --- Blood transfusion --- Blood transfusion therapy --- Hemotherapy --- Transfusion medicine --- Transfusion of blood --- Transfusion therapy --- Transfusion therapy, Blood --- Wounds and injuries --- Blood banks --- Blood groups --- Hospitals --- Transfusion-free surgery --- Transfusion committees

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Introduction The understanding of the genetic, epigenetic, immuno- well as for practicing hematologists or oncologists. logical and biological causes of myeloproliferative dis- Each chapter follows a similar architecture and leads orders has substantially improved in the last few years. through epidemiology, genetic and molecular causes, Together with refined tools in pathology, the successful hematological and clinical findings, prognostic factors establishment of mouse models mimicking at least some and current treatment approaches of the diseases. of the myeloproliferative disorders, and murine models Effort has been made to point out the evolving field of novel drugs in this arena but simultaneously diff- allowing to carefully dissect the role of mutations and gene dosage effects of, for example JAK2, this has led to entiate between standard and experimental treatment ever increasing numbers of modified classification approaches. schemes. It is therefore important for the heamtologist Together with the co-editors and all the authors of or oncologist to keep up with this rapid change in classi- the various chapters I hope that the readers of the book fication language, the upcoming of new entities or differ- will enjoy reading and benefit from the information entiation between, or subclassification of, rare diseases provided.

Myeloid leukemia --Epidemiology. --- Myeloid leukemia --Pathophysiology. --- Myeloid leukemia --Treatment. --- Myeloproliferative disorders --Epidemiology. --- Myeloproliferative disorders --Pathophysiology. --- Myeloproliferative disorders --Treatment. --- Myeloproliferative disorders --- Myeloid leukemia --- Bone Marrow Diseases --- Leukemia --- Leukemia, Myeloid --- Myeloproliferative Disorders --- Neoplasms by Histologic Type --- Hematologic Diseases --- Neoplasms --- Hemic and Lymphatic Diseases --- Diseases --- Medicine --- Oncology --- Health & Biological Sciences --- Epidemiology --- Pathophysiology --- Treatment --- Bone marrow --- Myeloproliferative disorders. --- Myelodysplastic syndromes. --- Diseases. --- Dysmyelopoietic syndromes --- Myeloproliferative syndrome --- Dysplasia --- Medicine. --- Internal medicine. --- Blood transfusion. --- Oncology. --- Medicine & Public Health. --- Internal Medicine. --- Blood Transfusion Medicine. --- Syndromes --- Preleukemia --- Oncology  . --- Blood transfusion --- Blood transfusion therapy --- Hemotherapy --- Transfusion medicine --- Transfusion of blood --- Transfusion therapy --- Transfusion therapy, Blood --- Surgery --- Blood banks --- Blood groups --- Hospitals --- Transfusion-free surgery --- Medicine, Internal --- Tumors --- Transfusion committees